Tłumaczenie nie jest jeszcze gotowe. Wyświetlamy oryginalny artykuł.
Precision oncology and digitally enabled cancer care are transforming what it means to live with cancer. The number of people in Europe alive more than five years after a cancer diagnosis grew 41 percent between 2010 and 2020, to nearly 15 million. As science progresses, a growing number of advanced cancers could be managed as chronic diseases, like diabetes or hypertension. But many patients are only able to access innovative treatments as part of a clinical trial, and Europe’s share of global commercial trials has almost halved in a decade. Access to screening and advanced diagnostics also varies widely across the bloc.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.